2025 annual financial data
Context Therapeutics 2025 Operating margin
Context Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -39,702,631 USD and net income was -36,123,615 USD.
Operating cash flow was -26,385,380 USD.
Get free Context Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -39,702,631 USD
- Net income
- -36,123,615 USD
- Operating cash flow
- -26,385,380 USD